Immunex Message Board - Msg: 3714823

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: synchro who wrote (208)	3/15/1998 2:04:00 AM
From: targetedmoab	of 656

I really dont understand Abelson. Hoerscts drug is pretty much like methyltrexate from the little I have seen. TNF receptor is a totally new entity that works by blocking TNF and what causes inflamation. They said Enbrel is not better than methyltrexate.....The recent data proves that wrong, that patients taking methyl. did much better when given Enbrel. If Hoerchts drug is close to approval and so good, why is there hardly any information on it? We have been hearing things from Immunex for over a year....Thing that make you go...HMMMM?????

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next